Edwards Lifesciences Cash on Hand 2010-2024 | EW

Edwards Lifesciences cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Edwards Lifesciences cash on hand for the quarter ending March 31, 2024 was $1.698B, a 35.35% increase year-over-year.
  • Edwards Lifesciences cash on hand for 2023 was $1.645B, a 35.32% increase from 2022.
  • Edwards Lifesciences cash on hand for 2022 was $1.215B, a 17.15% decline from 2021.
  • Edwards Lifesciences cash on hand for 2021 was $1.467B, a 4.58% increase from 2020.
Edwards Lifesciences Annual Cash on Hand
(Millions of US $)
2023 $1,645
2022 $1,215
2021 $1,467
2020 $1,403
2019 $1,517
2018 $957
2017 $1,338
2016 $1,271
2015 $1,225
2014 $1,439
2013 $937
2012 $521
2011 $451
2010 $396
2009 $334
Edwards Lifesciences Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $1,698
2023-12-31 $1,645
2023-09-30 $1,864
2023-06-30 $1,509
2023-03-31 $1,254
2022-12-31 $1,215
2022-09-30 $1,739
2022-06-30 $1,516
2022-03-31 $1,496
2021-12-31 $1,467
2021-09-30 $1,795
2021-06-30 $1,561
2021-03-31 $1,331
2020-12-31 $1,403
2020-09-30 $1,295
2020-06-30 $1,164
2020-03-31 $1,031
2019-12-31 $1,517
2019-09-30 $1,357
2019-06-30 $934
2019-03-31 $963
2018-12-31 $957
2018-09-30 $1,596
2018-06-30 $1,401
2018-03-31 $1,499
2017-12-31 $1,338
2017-09-30 $1,403
2017-06-30 $1,132
2017-03-31 $918
2016-12-31 $1,271
2016-09-30 $1,200
2016-06-30 $1,060
2016-03-31 $952
2015-12-31 $1,225
2015-09-30 $1,251
2015-06-30 $1,409
2015-03-31 $1,371
2014-12-31 $1,439
2014-09-30 $1,515
2014-06-30 $1,484
2014-03-31 $832
2013-12-31 $937
2013-09-30 $758
2013-06-30 $575
2013-03-31 $558
2012-12-31 $521
2012-09-30 $623
2012-06-30 $506
2012-03-31 $410
2011-12-31 $451
2011-09-30 $451
2011-06-30 $468
2011-03-31 $434
2010-12-31 $396
2010-09-30 $361
2010-06-30 $320
2010-03-31 $321
2009-12-31 $334
2009-09-30 $290
2009-06-30 $188
2009-03-31 $150
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $54.831B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.215B 25.35
Intuitive Surgical (ISRG) United States $157.544B 94.91
DexCom (DXCM) United States $45.360B 68.71
Alcon (ALC) Switzerland $45.237B 32.42
IQVIA Holdings (IQV) United States $40.844B 23.70
IDEXX Laboratories (IDXX) United States $40.694B 47.70
STERIS (STE) Ireland $21.918B 25.60
SONOVA HOLDING (SONVY) Switzerland $18.440B 0.00
Hologic (HOLX) United States $18.131B 20.28
Waters (WAT) United States $17.938B 26.36
Fresenius Medical Care AG KGaA (FMS) Germany $11.684B 13.64
Teleflex (TFX) United States $10.385B 16.16
Sysmex ADR (SSMXY) Japan $10.297B 32.29
Globus Medical (GMED) United States $9.621B 28.20
Penumbra (PEN) United States $7.398B 84.07
Glaukos (GKOS) United States $6.099B 0.00
Masimo (MASI) United States $5.954B 34.24
TransMedics (TMDX) United States $4.683B 444.34
Integer Holdings (ITGR) United States $4.028B 24.34
PROCEPT BioRobotics (PRCT) United States $3.566B 0.00
Inari Medical (NARI) United States $3.163B 0.00
Tandem Diabetes Care (TNDM) United States $2.976B 0.00
LivaNova (LIVN) United Kingdom $2.785B 16.54
Integra LifeSciences Holdings (IART) United States $2.365B 10.31
RxSight (RXST) United States $1.765B 0.00
Veracyte (VCYT) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.574B 0.00
Artivion (AORT) United States $1.138B 109.12
Silk Road Medical (SILK) United States $1.069B 0.00
Pulse Biosciences (PLSE) United States $1.026B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.968B 18.82
OPKO Health (OPK) United States $0.962B 0.00
OrthoPediatrics (KIDS) United States $0.780B 0.00
SiBone (SIBN) United States $0.631B 0.00
Paragon 28 (FNA) United States $0.629B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.592B 0.00
IRadimed (IRMD) United States $0.574B 32.17
Mesa Laboratories (MLAB) United States $0.571B 16.88
Treace Medical Concepts (TMCI) United States $0.504B 0.00
Pacific Biosciences Of California (PACB) United States $0.458B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
AxoGen (AXGN) United States $0.361B 0.00
Nevro (NVRO) United States $0.337B 0.00
Tactile Systems Technology (TCMD) United States $0.286B 9.77
AngioDynamics (ANGO) United States $0.240B 0.00
Semler Scientific (SMLR) United States $0.237B 12.01
Delcath Systems (DCTH) United States $0.224B 0.00
NeuroPace (NPCE) United States $0.214B 0.00
Inogen (INGN) United States $0.212B 0.00
CVRx (CVRX) United States $0.210B 0.00
ClearPoint Neuro (CLPT) United States $0.206B 0.00
Accuray (ARAY) United States $0.196B 0.00
EDAP TMS S.A (EDAP) France $0.183B 0.00
908 Devices (MASS) United States $0.183B 0.00
Atossa Genetics (ATOS) United States $0.165B 0.00
Alpha Tau Medical (DRTS) Israel $0.155B 0.00
KORU Medical Systems (KRMD) United States $0.121B 0.00
Spectral Diagnostics (EDTXF) Canada $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.101B 21.28
EnVVeno Medical (NVNO) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Neuronetics (STIM) United States $0.056B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
DarioHealth (DRIO) United States $0.043B 0.00
Precision Optics (POCI) United States $0.038B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Rapid Micro Biosystems (RPID) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
PAVmed (PAVM) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00